Itch Alert: How Elanco's New Insights Are Transforming Dogs' Lives

Introduction – a common discomfort
Itching is one of the most common complaints in dogs. Elanco's new report reveals surprising statistics and solutions that every dog ​​owner should know.

What does the report show?
In a survey of tens of thousands of dog owners, 9 out of 10 dogs reported experiencing itching in the past year. Pollen, dust mites, and fleas are the primary contributing factors.

Why is it important?
Untreated itching leads to skin damage, secondary infections, and behavioral problems. Veterinarians report that many owners underestimate the severity of the condition, which reduces their quality of life.

Zenrelia™: the game changer
Ilunocitinib (Zenrelia™) is a daily oral medication that targets the underlying immune response. Clinical data shows that it provides rapid relief with minimal side effects. This gives owners greater confidence in long-term itch control.

Role of the veterinarian

• Diagnosis : distinguish allergies from parasites or infections.
• Treatment : draw up a plan with medication and dietary advice.
• Follow-up : monitor skin condition and adjust therapy.

Tips for owners

1. Keep an itch diary : note down when and how often itching occurs.
2. Optimize living environment : avoid high pollen and dust levels.
3. Consider dietary changes : Hypoallergenic diets may reduce the need for medication.

Conclusion
Itching doesn't have to be a dog thing. With Elanco's insights and modern treatments like Zenrelia™, owners can be proactive, strengthen their bond with their dog, and enjoy an itch-free life together.